BeOne Medicines AG (FRA:49BA)

BeOne Medicines AG Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 20, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	34,015	18,997	17,064	21,374	24,483	19,206
Market Cap Growth	45.86%	11.32%	-20.16%	-12.70%	27.47%	112.69%
Enterprise Value	31,454	17,391	14,874	18,337	21,654	15,555
Last Close Price	300.00	172.00	162.00	206.00	226.00	202.00
PS Ratio	8.03	5.16	7.67	16.13	23.67	76.06
PB Ratio	9.66	5.90	5.33	5.21	4.54	6.07
P/TBV Ratio	9.82	5.99	5.42	5.26	4.58	6.08
P/OCF Ratio	50.81	-	-	-	-	-
EV/Sales Ratio	7.45	4.72	6.69	13.84	20.94	61.60
Debt / Equity Ratio	0.25	0.32	0.26	0.14	0.11	0.14
Net Debt / Equity Ratio	-0.73	-0.46	-0.63	-0.90	-0.97	-1.06
Net Debt / EBITDA Ratio	-9.19	3.85	1.99	2.28	4.25	2.52
Net Debt / FCF Ratio	-5.54	2.44	1.30	2.16	3.80	2.92
Asset Turnover	0.74	0.65	0.40	0.19	0.17	0.09
Inventory Turnover	1.43	1.30	1.09	1.09	0.99	23.18
Quick Ratio	2.09	1.51	1.97	3.22	4.45	4.40
Current Ratio	2.39	1.80	2.32	3.55	4.76	4.61
Return on Equity (ROE)	1.81%	-18.77%	-22.26%	-38.11%	-29.15%	-67.19%
Return on Assets (ROA)	1.69%	-6.07%	-12.40%	-15.00%	-12.72%	-28.73%
Return on Capital Employed (ROCE)	3.50%	-15.40%	-30.30%	-36.40%	-20.70%	-36.60%
Earnings Yield	0.17%	-3.28%	-4.67%	-8.77%	-5.24%	-6.92%
FCF Yield	1.36%	-3.22%	-9.12%	-7.98%	-5.61%	-5.96%
Buyback Yield / Dilution	-6.60%	-0.86%	-1.22%	-11.15%	-11.16%	-38.99%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.